Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd has announced an earnings conference call for Q1 FY 2026-27, scheduled to be held on August 10, 2026, at 4:00 P.M. IST. The call will be hosted by Go India Advisors and will feature company participants Ramesh Kumar, Managing Director, and Aditya Arora, Director & CFO.

Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd has announced an earnings conference call for Q1 FY 2026-27, scheduled on August 10, 2026, at 4:00 P.M. IST. The call will be hosted by Go India Advisors and will feature company participants Ramesh Kumar, Managing Director, and Aditya Arora, Director & CFO.

Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd has scheduled a board meeting on August 10, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.

Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals receives CDSCO approval to initiate preclinical pilot batches of Pembroluzimab, a significant milestone in its biologics development journey.